HTRA2 variants represent a novel and significant cause of rapidly progressing, neonatal onset mitochondrial disease associated with 3-MGA-uria, hypotonia, dystonia, seizures and cardio-respiratory difficulties. The gene discussed is HTRA2; the disease is inborn mitochondrial metabolism disorder.